Interview: Interview with Dr you han bae: Ligand-mediated versus 'passive targeting approaches in nanoparticle oncology research

Therapeutic Delivery

Volumn 3, Issue 8, 2012, Pages 933-936

  Bae, You Han ^a  

^a Department of Pharmaceutics and Pharmaceutical Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; LIGAND;

CANCER INHIBITION; CANCER RESEARCH; COST BENEFIT ANALYSIS; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RESEARCH; DRUG TARGETING; HUMAN VERSUS ANIMAL COMPARISON; INTERVIEW; LIGAND MEDIATED DRUG DELIVERY SYSTEM; MEDICAL RESEARCH; MOLECULAR INTERACTION; MULTIDRUG RESISTANCE; NANOPHARMACEUTICS; NANOTECHNOLOGY; NOMENCLATURE; NOTE; PASSIVE TARGETING DRUG DELIVERY SYSTEM; PRIORITY JOURNAL; ARTICLE; HUMAN; METHODOLOGY; ONCOLOGY;

DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; MEDICAL ONCOLOGY; NANOPARTICLES;

EID: 84865473327     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.62     Document Type: Note

References (0)